Biotech Nephrogen: Combining AI and Gene Therapy to Reverse Kidney Disease
Demetri Maxim's life was affected by kidney disease at a young age, when his mother's kidneys stopped working and she had to undergo dialysis.
Maxim's mother later received a kidney transplant, but he inherited Polycystic Kidney Disease (PKD) from her. About 1 in 7 Americans have Chronic Kidney Disease (CKD), with 10% of cases due to genetic conditions.
Maxim became determined to find a cure, and his breakthrough moment came in 2021 when Nature Magazine published a study showing that PKD can be reversed in mice using CRISPR technology.
Maxim has been obsessed with finding a cure for himself and others ever since he was in high school.
Learn more about Biotech Nephrogen's innovative approach at TechCrunch Disrupt 2025.
Author's summary: Biotech Nephrogen uses AI and gene therapy to fight kidney disease.
More News
- SJHN Daily: Celebrini Named NHL First Star of the Week
- Syngene International announces plans to add bioconjugation suite for end-to-end Antibody-Drug Conjugates Development
- Praia Health’s Kurt Hammond on Powering Providence’s Work With Labcorp
- Waymo co-CEO on robotaxi vandalism: 'We're not standing for it' | TechCrunch
- Eglin battalion chief and wife lose Crestview home to lightning strike, community rallies in support
- GSK Agrees to $357 Million Exclusive License Agreement for Syndivia’s AntiBody-Drug Conjugate | PharmExec
- MCU: Jeremy Allen White Responds to Popular X-Men Fan Casting
- Amazon reportedly plans to cut around 30,000 corporate jobs | TechCrunch
- The Passport relaunches its cocktail and wine bar in the Loop in November
- State begins distributing disaster aid to residents of Western Alaska, federal aid also approved